XML 19 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenues
Operating Expenses:    
General, selling, and administrative 26,768 20,090
Research and development 21,342 17,031
Total operating expenses 48,110 37,121
Operating loss (48,110) (37,121)
Other income 4,203 2,214
Net Loss $ (43,907) $ (34,907)
Weighted average loss per share of Class A and Class B common stock - basic $ (1.79) $ (1.52)
Weighted average loss per share of Class A and Class B common stock - diluted $ (1.79) $ (1.52)
Weighted average shares outstanding of Class A and B common stock - basic 24,492,781 23,036,809
Weighted average shares outstanding of Class A and B common stock - diluted 24,492,781 23,036,809